Exonin CR Extended Release Tablet (Eperisone Hydrochloride)

Adult dose

This medication is an extended-release tablet and should be taken whole without crushing, splitting, or chewing. Administer orally after meals at a dose of 1 tablet (75 mg of eperisone hydrochloride) twice a day. Adjust the dose as appropriate according to age and symptoms.

This medication should not be used in patients with hypersensitivity to this medication or in patients with severe myasthenia gravis. Caution should be exercised when administering this medication to patients with a history of hypersensitivity to the drug or liver dysfunction, as there is a risk of worsening liver function. Rarely, severe allergic reactions such as anaphylaxis may occur during treatment with this medication, so if symptoms such as redness, itching, hives, swelling, or difficulty breathing appear, the medication should be discontinued immediately and appropriate treatment should be given. Additionally, symptoms of serious skin conditions such as toxic epidermal necrolysis or Stevens-Johnson syndrome may occur, so careful observation of symptoms such as fever, erythema, blisters, itching, conjunctival injection, and stomatitis is required. Various side effects such as liver or kidney dysfunction, anemia, rashes, itching, headaches, drowsiness, nausea, vomiting, constipation, diarrhea, abdominal pain, urinary retention, weakness, and dizziness can occur; therefore, consulting a healthcare professional is advised if abnormal symptoms arise. Drowsiness, weakness, or dizziness may occur during the use of this medication, and it may be necessary to reduce the dose or stop administration if such symptoms arise. Drowsiness or decreased attention may be present, so one should refrain from driving or operating dangerous machinery. Additionally, caution is required when taking this medication in conjunction with drugs containing similar ingredients, as visual disturbances may occur. Women who are pregnant or may become pregnant should only use this medication when the benefits of treatment outweigh the risks, as its safety has not been established. Nursing mothers should avoid taking this medication or discontinue breastfeeding during treatment. Safety in children has not been sufficiently established; therefore, caution is advised in usage.

Serious side effects

• Hives
• swelling
• difficulty breathing
• fever
• erythema
• blisters
• itching
• conjunctival injection
• stomatitis
• headaches

Mild side effects

• Redness
• itching
• hives
• swelling
• stomatitis
• conjunctival injection
• nausea
• vomiting
• loss of appetite
• discomfort in the upper abdomen

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius. This will help to safely and effectively preserve the medication’s efficacy for an extended period.

Appearance

White to almost white, round, extended-release film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle